International Journal on Science and Technology
E-ISSN: 2229-7677
•
Impact Factor: 9.88
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJSAT
Upcoming Conference(s) ↓
Conferences Published ↓
ALSDAHW-2025
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 17 Issue 2
April-June 2026
Indexing Partners
Matrix-Aware Optimization of Carboxypeptidase B (CPB) Treatment Using Human Serum to Support Cation-Exchange (CEX) Method Development for Monoclonal Antibodies and Fusion Proteins
| Author(s) | Jasmine Jinugu |
|---|---|
| Country | United States |
| Abstract | Charge variant profiling is a critical component of analytical control strategies for monoclonal antibodies (mAbs) and fusion proteins, with cation-exchange chromatography (CEX) serving as a widely used reference technique for resolving acidic, main, and basic species. [18] [23] [24] A common contributor to basic species is C-terminal Lys/Arg heterogeneity, which can be normalized analytically through carboxypeptidase B (CPB) treatment to remove C-terminal basic residues prior to charge profiling. [13] [14] [15] However, CPB performance can be impacted by matrix effects, including inhibition by formulation components or biological matrices, motivating a “matrix-aware” optimization strategy. [13] This manuscript presents a research-style, publication-ready framework for optimizing CPB activity in the presence of human serum (as a representative complex matrix) and integrating that optimization into CEX method development for both mAbs and fusion proteins. [13] [18] [25] We summarize relevant enzyme properties and kinetics, propose a Design of Experiments (DoE) approach for robust CPB condition selection, and outline how optimized CPB treatment improves interpretability of CEX charge variant profiles while supporting fit-for-purpose validation per ICH guidance. [2] [22] Figures include workflow schematics, illustrative kinetics and DoE response surfaces, and representative CEX chromatogram presentations (simulated placeholders intended to be replaced by experimental chromatograms). [18] [25] |
| Keywords | Carboxypeptidase B, CPB; CPB2/CPU, thrombin-activatable fibrinolysis inhibitor, monoclonal antibodies, fusion proteins, charge variants, cation exchange chromatography, pH gradient, matrix effects, serum inhibition, method development; ICH Q2(R2). [1] [6] [7] [18] [22] |
| Field | Engineering |
| Published In | Volume 17, Issue 2, April-June 2026 |
| Published On | 2026-04-04 |
| DOI | https://doi.org/10.71097/IJSAT.v17.i2.11024 |
Share this

CrossRef DOI is assigned to each research paper published in our journal.
IJSAT DOI prefix is
10.71097/IJSAT
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.